Publication Detail
The publication detail shows the title, authors (with indicators showing other profiled authors), information on the publishing organization, abstract and a link to the article in Scopus. This abstract is what is used to create the fingerprint of the publication.
Axillary recurrence in women with a negative sentinel lymph node and no axillary dissection in breast cancer
J. Alexander Palesty; Jason M. Foster; Thelma C. Hurd; Nancy Watroba; Hamed Rezaishiraz; Stephen B. Edge (Profiled Author: Jason M Foster)
Journal of Surgical Oncology 2006;93(2):129-132.
AbstractObjectives: Sentinel lymph node biopsy (SLNB) is widely used for staging breast cancer. SLNB accurately determines axillary lymph node status with a low false negative rate. There remains concern that omitting axillary dissection may lead to recurrence in the axilla, and impact long term survival. The purpose of this study was to determine the frequency of axillary lymph node recurrence in patients who had a negative sentinel lymph node and did not undergo axillary node dissection. Methods: Data was collected on all patients who had negative SLNB at Roswell Park Cancer Institute between July 1997 and June 2002. Demographics, type of operation, postoperative systemic, and radiation therapy, co-morbidity score, hormone receptor status, and the pathologic features of the tumor were abstracted for each patient. For each woman with recurrence, the dates of recurrence, the site(s) of recurrence, and the treatment for recurrence were recorded. Results: With a median follow-up of 33 months, 15 of 335 (4.5%) women who had negative SLNBs and who did not undergo completion axillary dissection developed a cancer recurrence. Only two patients (0.6%) had an axillary recurrence. Conclusions: The rate of axillary recurrence following a negative sentinel node biopsy is the same or less than axillary lymph node dissection (ALND) alone. Concerns that omitting completion axillary dissection following a negative SLNB will increase the rate of axillary recurrence appear unfounded. © 2006 Wiley-Liss, Inc.
Scientific Context
This section shows information related to the publication - computed using the fingerprint of the publication - including related publications, related experts with fingerprints representing significant amounts of overlap between their fingerprint and this publication. The red dots indicate whether those experts or terms appear within the publication, thereby showing potential and actual connections.
Related Publications
-
1.
2009Robert W. Carlson; D. Craig Alfred; Benjamin O. Anderson; Harold J. Burstein; W. Bradford Carter; Stephen B. Edge; John K. Erban; William B. Farrar; Lori J. Goldstein; William J. Gradishar; et al.
Breast cancer: Clinical Practice Guidelines in Oncology™
JNCCN Journal of the National Comprehensive Cancer Network 2009;7(2):122-192. -
2.
1992D.M. Radford; D.T. Cromack; B.R. Troop; S.M. Keller; M.J. Lopez; K.C. Westbrook; J. Ballard; J.A. Edney; J.B. Moore
Pathology and treatment of impalpable breast lesions
American Journal of Surgery 1992;164(5):427-432. -
3.
1998David N. Danforth Jr.; JoAnne Zujewski; Joyce O'Shaughnessy; David Riseberg; Seth M. Steinberg; Nanette McAtee; Marianne Noone; Catherine Chow; Usha Chaudhry; et al.
Annals of Surgical Oncology 1998;5(2):150-158.
Related Experts
Author of this Document
-
Internal ExpertsPublications
-
19









-
217









-
97









-
211









-
44









-
265










Export